We are live on
!
Find out more
ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
151 hedge funds and large institutions have $578M invested in Array Biopharma Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
7% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 45
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 157 → 151 (-6)
11% less capital invested
Capital invested by funds: $653M → $578M (-$75M)
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
44% less call options, than puts
Call options by funds: $6.85M | Put options by funds: $12.2M
Holders
151
Holders Change
-6
Holders Change %
-3.82%
% of All Funds
3.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
48
Reduced
45
Closed
28
Calls
$6.85M
Puts
$12.2M
Net Calls
-$5.33M
Net Calls Change
-$7.65M
Top Buyers
| 1 |
Millennium Management
New York
|
+$11.1M |
| 2 |
Renaissance Technologies
New York
|
+$10.4M |
| 3 |
VAM
Visium Asset Management
New York
|
+$9.08M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.86M |
| 5 |
TA
Teachers Advisors
New York
|
+$4.77M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$23.5M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$16.6M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$13.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$10.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.54M |
